Cargando…
Treatment of HT29 Human Colorectal Cancer Cell Line with Nanocarrier-Encapsulated Camptothecin Reveals Histone Modifier Genes in the Wnt Signaling Pathway as Important Molecular Cues for Colon Cancer Targeting
Cancer cells are able to proliferate in an unregulated manner. There are several mechanisms involved that propel such neoplastic transformations. One of these processes involves bypassing cell death through changes in gene expression and, consequently, cell growth. This involves a complex epigenetic...
Autores principales: | Farhana, Aisha, Koh, Avin Ee-Hwan, Kothandan, Sangeetha, Alsrhani, Abdullah, Mok, Pooi Ling, Subbiah, Suresh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623831/ https://www.ncbi.nlm.nih.gov/pubmed/34830168 http://dx.doi.org/10.3390/ijms222212286 |
Ejemplares similares
-
Camptothecin Encapsulated in β-Cyclodextrin-EDTA-Fe(3)O(4) Nanoparticles Induce Metabolic Reprogramming Repair in HT29 Cancer Cells through Epigenetic Modulation: A Bioinformatics Approach
por: Farhana, Aisha, et al.
Publicado: (2021) -
Nanoparticle-Encapsulated Camptothecin: Epigenetic Modulation in DNA Repair Mechanisms in Colon Cancer Cells
por: Farhana, Aisha, et al.
Publicado: (2021) -
In silico Prediction of Deleterious Single Nucleotide Polymorphism in S100A4 Metastatic Gene: Potential Early Diagnostic Marker
por: Farhana, Aisha, et al.
Publicado: (2022) -
Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach
por: Mok, Pooi Ling, et al.
Publicado: (2021) -
Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe(3)O(4) nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug
por: Krishnan, Poorani, et al.
Publicado: (2017)